Boston Scientific (BSX) Fair Value & DCF
Score
BSX fair value $86.71. Price $44.34. Price is 49% below fair value.
Worked example
Cash-flow value. Starting free cash flow is $2.30 a share. Year 1 is the first earnings forecast, so it has no growth rate of its own. The forecast then reaches 9.80%, and that pace fades in a straight line to 3% terminal growth by year 10. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $80.77 a share.
Earnings value. Next-twelve-months earnings per share of $3.09 times 30.00 is $92.64. The peer group is Medical - Devices, 10 companies worth at least $10 billion. Peer median 28.6. Own 10-year median 57.4. The multiple used is the average of the two, kept between 8 and 30, which is 30.00.
Fair value is the average of the two, $86.71. The price is $44.34, which is 48.9% below fair value.